News

cardiologists heart doctors

The J-Valve System is associated with positive 10-year outcomes for patients with severe AR, according to new research out of China. It also performs well in patients with severe AS.

heart drugs with stethoscope

An experimental oral PCSK9 inhibitor is associated with LDL-C reductions that could prove to be a game-changer for patient care. 

SCAI has shared a new call to action as an observance of American Heart Month. The group is asking Congress to pass new pieces of legislation that could improve care for PAD patients and get important medical devices in the hands of interventional cardiologists.

Cerepak Detachable Coil Systems

Several detachable coil systems are being recalled due to a higher-than-expected failure to detach rate. Customers should not use them going forward.

the words "FDA recall" on a board

New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness. 

heart surgery surgeons

Survival rates are high for both men and women presenting with BAV disease, according to a new analysis of nearly 28,000 SAVR patients.

Open surgical bypass is the gold standard, but endovascular therapies may provide value for high-risk patients with long femoropopliteal lesions.

The cardiologist at the head of an influential CDC panel sees serious problems with modern vaccine policies. While many experts seem to disagree, one organization has jumped to his defense. 

The U.S. Food and Drug Administration (FDA) this week has the first cleared the pulsed field ablation (PFA) system, the Medtronic PulseSelect System for the treatment of both paroxysmal and persistent atrial fibrillation (AF).

"The PulseSelect PFA system ushers the EP community to a new era of safe, effective and efficient AF ablation that overcomes many challenges in our current practice," said Amin Al-Ahmad, MD, St. David's Medical Center in Austin, Texas. 

Connected Cardiovascular Care Associates (C3) in Dallas is the first U.S. cardiology practice to install a dedicated Arineta Spotlight cardiac CT system. It is designed for outpatient settings and it the first install since Arineta ended its partnership with GE Healthcare where the scanner was previously known as the Cardiograph.

The news marks the first provider organization in the U.S. install of one of Arineta's systems since the end of its partnership with GE HealthCare.

Cardiology makes up 10% of the 692 market-cleared clinical AI algorithms in the FDA’s latest update on the number of patient-facing AI now commercialized in the U.S. Experts share their thoughts on how it is being used.

AI artificial intelligence stethoscope doctor

AI-based prediction models have shown significant promise, but many are still flawed in a way that limits their value. 

Around the web

Tim Szczykutowicz, PhD, associate professor radiology, University of Wisconsin Madison, explains the new technology developments in GE HealthCare's  FDA 510(k)-pending photon-counting CT scanner.